Literature DB >> 29789989

Influence of tissue factor polymorphisms (603A>G and 5466A>G) on plasma tissue factor levels and their impact on deep vein thrombosis risk in young Indian population.

Kamal Kishor1, Amit Sharma1, Kanwaljeet Singh1, Ravi Ranjan1, Hareram Pandey1, Ravi Kumar1, Vineet Kumar Kamal2, Pravas Mishra1, Manoranjan Mahapatra1, Renu Saxena3,4.   

Abstract

Deep vein thrombosis (DVT) is multifactorial disorder and well known to cause substantial morbidity and mortality. There is sparse data in the Asian population, particularly India regarding association of tissue factor (TF) gene single nucleotide polymorphisms (SNPs) with plasma TF levels in DVT. So, we analyzed the distribution of SNPs (603A>G and 5466A>G) in India, to evaluate their effect on TF levels in DVT patients. Plasma level and SNPs (603A>G and 5466A>G) of TF gene were screened in subjects (100 DVT patients and 100 controls). Patients had significantly higher TF levels than controls (patients: 84.95 ± 17.16 pg/ml, controls: 70.55 ± 15.87 pg/ml, p < 0.001). G allele of 603A>G polymorphism was significantly higher in patients than controls (patients: 40.5% controls: 27.5%, p = 0.004). Subjects with AG and GG genotype had significantly higher TF levels than AA genotype (p = 0.001). After multiple logistic regression analysis, risk of DVT was increased 1.398 fold (95% CI 0.738-2.651) and 4.41 fold (95% CI 1.404-13.884) with AG and GG genotype respectively. Allelic and genotypic frequencies of 5466A>G polymorphism was neither associated with TF levels nor with DVT. We found high TF level in patients with TF 603A>G polymorphism, which is an important predisposing factor in increasing risk of DVT in young Indians. Furthermore, GG genotype of 603A>G polymorphism augments the risk of thrombosis by 4.4 fold, thus highlighting the significance of this polymorphism in the development of DVT. So, we suggest that inclusion of 603A>G polymorphism in prothrombotic work-up may be helpful in making the treatment strategy in DVT patients.

Entities:  

Keywords:  Deep vein thrombosis; Genotype; Single nucleotide polymorphisms; Tissue factor

Mesh:

Substances:

Year:  2018        PMID: 29789989     DOI: 10.1007/s11239-018-1666-6

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  24 in total

1.  Prognostic value of plasma tissue factor and tissue factor pathway inhibitor for cardiovascular death in patients with coronary artery disease: the AtheroGene study.

Authors:  P E Morange; S Blankenberg; M C Alessi; C Bickel; H J Rupprecht; R Schnabel; E Lubos; T Münzel; D Peetz; V Nicaud; I Juhan-Vague; L Tiret
Journal:  J Thromb Haemost       Date:  2007-01-04       Impact factor: 5.824

Review 2.  Factor V Leiden and other coagulation factor mutations affecting thrombotic risk.

Authors:  R M Bertina
Journal:  Clin Chem       Date:  1997-09       Impact factor: 8.327

3.  Heightened tissue factor associated with tissue factor pathway inhibitor and prognosis in patients with unstable angina.

Authors:  H Soejima; H Ogawa; H Yasue; K Kaikita; K Nishiyama; K Misumi; K Takazoe; Y Miyao; M Yoshimura; K Kugiyama; S Nakamura; I Tsuji; K Kumeda
Journal:  Circulation       Date:  1999-06-08       Impact factor: 29.690

4.  Polymorphisms in the 5' regulatory region of the tissue factor gene and the risk of myocardial infarction and venous thromboembolism: the ECTIM and PATHROS studies. Etude Cas-Témoins de l'Infarctus du Myocarde. Paris Thrombosis case-control Study.

Authors:  E Arnaud; V Barbalat; V Nicaud; F Cambien; A Evans; C Morrison; D Arveiler; G Luc; J B Ruidavets; J Emmerich; J N Fiessinger; M Aiach
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-03       Impact factor: 8.311

Review 5.  Epidemiology and risk factors for venous thrombosis.

Authors:  Mary Cushman
Journal:  Semin Hematol       Date:  2007-04       Impact factor: 3.851

Review 6.  The aetiology of deep venous thrombosis.

Authors:  P C Malone; P S Agutter
Journal:  QJM       Date:  2006-08-12

7.  Elevated tissue factor and tissue factor pathway inhibitor circulating levels in ischaemic heart disease patients.

Authors:  M Falciani; A M Gori; S Fedi; L Chiarugi; I Simonetti; R P Dabizzi; D Prisco; G Pepe; R Abbate; G F Gensini; G G Neri Serneri
Journal:  Thromb Haemost       Date:  1998-03       Impact factor: 5.249

8.  Role of risk factors in the modulation of tissue factor activity and blood thrombogenicity.

Authors:  Antonia Sambola; Julio Osende; James Hathcock; Michael Degen; Yale Nemerson; Valentin Fuster; Jill Crandall; Juan Jose Badimon
Journal:  Circulation       Date:  2003-02-25       Impact factor: 29.690

9.  Gender differences of polymorphisms in the TF and TFPI genes, as related to phenotypes in patients with coronary heart disease and type-2 diabetes.

Authors:  Trine B Opstad; Alf Age Pettersen; Thomas Weiss; Harald Arnesen; Ingebjørg Seljeflot
Journal:  Thromb J       Date:  2010-05-05

Review 10.  Tissue factor in acute coronary syndromes.

Authors:  Ilka Ott
Journal:  Semin Vasc Med       Date:  2003-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.